Skip to main content

Liver Mate (Pharma Botanica Pty Ltd)

Product Name
Liver Mate
Date of review outcome
Date of publication
Jun-2024
Outcome
Medicine continues to be permitted for supply. Batches released after May 2024 must carry corrected labels.
Is it safe to continue using this medicine?
Yes, based on the sponsor's certification. However, use of this medicine may pose a safety risk for some people. Follow the recommended actions below.
What action should consumers take?
Seek advice from a medical practitioner if you have been taking this medicine to treat fatty liver disease.
Consider whether this medicine is right for you based on it potentially not working as expected in relation to 'aid in absorption', cold sores, reflux, and weight loss.
Review scope
Targeted
Information reviewed
ARTG Record, Labels, Website
Issues related to safety
The website for this medicine contained claims regarding the conditions specified in 'What actions should consumers take?'. Some of these claims are not permitted for listed medicines without prior evaluation or approval from the TGA. References to non-permitted claims have the potential to lead consumers to delay access to timely advice or treatment from a medical practitioner when required, which may result in adverse outcomes.
While advertising of this nature is unacceptable, these claims have been removed. As such, this medicine is unlikely to pose an immediate risk to consumer health and safety.
Issues related to efficacy
The label and website for this medicine contained claims specified in 'What action should consumers take?' above. However, these claims were not covered by the sponsor's certification that they held evidence to substantiate them.
Actions taken during the review
The TGA required the sponsor to correct the issues with this medicine. The sponsor removed the unsupported claims from the label and website to correct the issue.

Help us improve the Therapeutic Goods Administration site